Global Sexually Transmitted Diseases Testing Market Research Report 2023

Report ID: 1900100 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chlamydia Testing
        1.2.3 Gonorrhea Testing
        1.2.4 Syphilis Testing
        1.2.5 HIV Testing
        1.2.6 HSV Testing
        1.2.7 HPV Testing
        1.2.8 Chancroid Testing
        1.2.9 Other
    1.3 Market by Application
        1.3.1 Global Sexually Transmitted Diseases Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Clinics
        1.3.3 Hospitals
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sexually Transmitted Diseases Testing Market Perspective (2017-2028)
    2.2 Sexually Transmitted Diseases Testing Growth Trends by Region
        2.2.1 Sexually Transmitted Diseases Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sexually Transmitted Diseases Testing Historic Market Size by Region (2017-2022)
        2.2.3 Sexually Transmitted Diseases Testing Forecasted Market Size by Region (2023-2028)
    2.3 Sexually Transmitted Diseases Testing Market Dynamics
        2.3.1 Sexually Transmitted Diseases Testing Industry Trends
        2.3.2 Sexually Transmitted Diseases Testing Market Drivers
        2.3.3 Sexually Transmitted Diseases Testing Market Challenges
        2.3.4 Sexually Transmitted Diseases Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sexually Transmitted Diseases Testing Players by Revenue
        3.1.1 Global Top Sexually Transmitted Diseases Testing Players by Revenue (2017-2022)
        3.1.2 Global Sexually Transmitted Diseases Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Sexually Transmitted Diseases Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sexually Transmitted Diseases Testing Revenue
    3.4 Global Sexually Transmitted Diseases Testing Market Concentration Ratio
        3.4.1 Global Sexually Transmitted Diseases Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases Testing Revenue in 2021
    3.5 Sexually Transmitted Diseases Testing Key Players Head office and Area Served
    3.6 Key Players Sexually Transmitted Diseases Testing Product Solution and Service
    3.7 Date of Enter into Sexually Transmitted Diseases Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases Testing Breakdown Data by Type
    4.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Type (2017-2022)
    4.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2023-2028)
5 Sexually Transmitted Diseases Testing Breakdown Data by Application
    5.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Application (2017-2022)
    5.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Sexually Transmitted Diseases Testing Market Size (2017-2028)
    6.2 North America Sexually Transmitted Diseases Testing Market Size by Country (2017-2022)
    6.3 North America Sexually Transmitted Diseases Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Sexually Transmitted Diseases Testing Market Size (2017-2028)
    7.2 Europe Sexually Transmitted Diseases Testing Market Size by Country (2017-2022)
    7.3 Europe Sexually Transmitted Diseases Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size (2017-2028)
    8.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Sexually Transmitted Diseases Testing Market Size (2017-2028)
    9.2 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2017-2022)
    9.3 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size (2017-2028)
    10.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 BioMerieux
        11.1.1 BioMerieux Company Detail
        11.1.2 BioMerieux Business Overview
        11.1.3 BioMerieux Sexually Transmitted Diseases Testing Introduction
        11.1.4 BioMerieux Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.1.5 BioMerieux Recent Development
    11.2 F. Hoffmann La Roche
        11.2.1 F. Hoffmann La Roche Company Detail
        11.2.2 F. Hoffmann La Roche Business Overview
        11.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Introduction
        11.2.4 F. Hoffmann La Roche Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.2.5 F. Hoffmann La Roche Recent Development
    11.3 BD
        11.3.1 BD Company Detail
        11.3.2 BD Business Overview
        11.3.3 BD Sexually Transmitted Diseases Testing Introduction
        11.3.4 BD Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.3.5 BD Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Detail
        11.4.2 Abbott Business Overview
        11.4.3 Abbott Sexually Transmitted Diseases Testing Introduction
        11.4.4 Abbott Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.4.5 Abbott Recent Development
    11.5 Bio-Rad Laboratories
        11.5.1 Bio-Rad Laboratories Company Detail
        11.5.2 Bio-Rad Laboratories Business Overview
        11.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Introduction
        11.5.4 Bio-Rad Laboratories Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.5.5 Bio-Rad Laboratories Recent Development
    11.6 Abbott
        11.6.1 Abbott Company Detail
        11.6.2 Abbott Business Overview
        11.6.3 Abbott Sexually Transmitted Diseases Testing Introduction
        11.6.4 Abbott Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.6.5 Abbott Recent Development
    11.7 Qiagen
        11.7.1 Qiagen Company Detail
        11.7.2 Qiagen Business Overview
        11.7.3 Qiagen Sexually Transmitted Diseases Testing Introduction
        11.7.4 Qiagen Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
        11.7.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chlamydia Testing
    Table 3. Key Players of Gonorrhea Testing
    Table 4. Key Players of Syphilis Testing
    Table 5. Key Players of HIV Testing
    Table 6. Key Players of HSV Testing
    Table 7. Key Players of HPV Testing
    Table 8. Key Players of Chancroid Testing
    Table 9. Key Players of Other
    Table 10. Global Sexually Transmitted Diseases Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Sexually Transmitted Diseases Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Sexually Transmitted Diseases Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Sexually Transmitted Diseases Testing Market Share by Region (2017-2022)
    Table 14. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Sexually Transmitted Diseases Testing Market Share by Region (2023-2028)
    Table 16. Sexually Transmitted Diseases Testing Market Trends
    Table 17. Sexually Transmitted Diseases Testing Market Drivers
    Table 18. Sexually Transmitted Diseases Testing Market Challenges
    Table 19. Sexually Transmitted Diseases Testing Market Restraints
    Table 20. Global Sexually Transmitted Diseases Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Sexually Transmitted Diseases Testing Market Share by Players (2017-2022)
    Table 22. Global Top Sexually Transmitted Diseases Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2021)
    Table 23. Ranking of Global Top Sexually Transmitted Diseases Testing Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Sexually Transmitted Diseases Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Sexually Transmitted Diseases Testing Product Solution and Service
    Table 27. Date of Enter into Sexually Transmitted Diseases Testing Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Sexually Transmitted Diseases Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2022)
    Table 31. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type (2023-2028)
    Table 33. Global Sexually Transmitted Diseases Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2022)
    Table 35. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Sexually Transmitted Diseases Testing Revenue Market Share by Application (2023-2028)
    Table 37. North America Sexually Transmitted Diseases Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Sexually Transmitted Diseases Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Sexually Transmitted Diseases Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Europe Sexually Transmitted Diseases Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 42. Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 43. Latin America Sexually Transmitted Diseases Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Latin America Sexually Transmitted Diseases Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 47. BioMerieux Company Detail
    Table 48. BioMerieux Business Overview
    Table 49. BioMerieux Sexually Transmitted Diseases Testing Product
    Table 50. BioMerieux Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 51. BioMerieux Recent Development
    Table 52. F. Hoffmann La Roche Company Detail
    Table 53. F. Hoffmann La Roche Business Overview
    Table 54. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Product
    Table 55. F. Hoffmann La Roche Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 56. F. Hoffmann La Roche Recent Development
    Table 57. BD Company Detail
    Table 58. BD Business Overview
    Table 59. BD Sexually Transmitted Diseases Testing Product
    Table 60. BD Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 61. BD Recent Development
    Table 62. Abbott Company Detail
    Table 63. Abbott Business Overview
    Table 64. Abbott Sexually Transmitted Diseases Testing Product
    Table 65. Abbott Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. Bio-Rad Laboratories Company Detail
    Table 68. Bio-Rad Laboratories Business Overview
    Table 69. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Product
    Table 70. Bio-Rad Laboratories Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 71. Bio-Rad Laboratories Recent Development
    Table 72. Abbott Company Detail
    Table 73. Abbott Business Overview
    Table 74. Abbott Sexually Transmitted Diseases Testing Product
    Table 75. Abbott Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 76. Abbott Recent Development
    Table 77. Qiagen Company Detail
    Table 78. Qiagen Business Overview
    Table 79. Qiagen Sexually Transmitted Diseases Testing Product
    Table 80. Qiagen Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 81. Qiagen Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sexually Transmitted Diseases Testing Market Share by Type: 2021 VS 2028
    Figure 2. Chlamydia Testing Features
    Figure 3. Gonorrhea Testing Features
    Figure 4. Syphilis Testing Features
    Figure 5. HIV Testing Features
    Figure 6. HSV Testing Features
    Figure 7. HPV Testing Features
    Figure 8. Chancroid Testing Features
    Figure 9. Other Features
    Figure 10. Global Sexually Transmitted Diseases Testing Market Share by Application in 2021 & 2028
    Figure 11. Clinics Case Studies
    Figure 12. Hospitals Case Studies
    Figure 13. Other Case Studies
    Figure 14. Sexually Transmitted Diseases Testing Report Years Considered
    Figure 15. Global Sexually Transmitted Diseases Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Sexually Transmitted Diseases Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Sexually Transmitted Diseases Testing Market Share by Region: 2021 VS 2028
    Figure 18. Global Sexually Transmitted Diseases Testing Market Share by Players in 2021
    Figure 19. Global Top Sexually Transmitted Diseases Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases Testing Revenue in 2021
    Figure 21. North America Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America Sexually Transmitted Diseases Testing Market Share by Country (2017-2028)
    Figure 23. United States Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Sexually Transmitted Diseases Testing Market Share by Country (2017-2028)
    Figure 27. Germany Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Sexually Transmitted Diseases Testing Market Share by Region (2017-2028)
    Figure 35. China Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Sexually Transmitted Diseases Testing Market Share by Country (2017-2028)
    Figure 43. Mexico Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Sexually Transmitted Diseases Testing Market Share by Country (2017-2028)
    Figure 47. Turkey Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia Sexually Transmitted Diseases Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. BioMerieux Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 50. F. Hoffmann La Roche Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 51. BD Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 52. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 54. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 55. Qiagen Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioMerieux
F. Hoffmann La Roche
BD
Abbott
Bio-Rad Laboratories
Abbott
Qiagen
Frequently Asked Questions
Sexually Transmitted Diseases Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sexually Transmitted Diseases Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sexually Transmitted Diseases Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

SFF Board

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Shadow Banking

Shadow Banking market is segmented by players, region (country), by Type and by Application. Play ... Read More

Shaft Couplings

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Shale Oil

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More